Agenus Inc

USPTO Trademark & Patent Filings

Trademark applications and grants for Agenus Inc. Agenus Inc has 42 trademark applications. The latest application filed is for "BOTVYMO"

Company Profile

Agenus Inc.
AGENUS INC. - Lexington MA US
Agenus Inc. - Lexington MA US

Trademarks Patents

Patent Applications

Patent Application	Date
ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF 20220275049 - 17/582445 MORIN; Benjamin Maxime ; et al.	2022-09-01
ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF 20220267443 - 17/582839 Van DIJK; Marc ; et al.	2022-08-25
ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF 20220257733 - 17/582548 UNDERWOOD; Dennis John ; et al.	2022-08-18
ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF 20220235349 - 17/646554 Xiao; Yanping ; et al.	2022-07-28
ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF 20220106581 - 17/379796 XIAO; Yanping ; et al.	2022-04-07

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"BOTVYMO" 98264722	BOTVYMO 2023-11-10
"AGENUS" 97886578	AGENUS 2023-04-13
"ZALIHANCE" 97652324	ZALIHANCE 2022-10-28
"EVAMPLIX" 97652406	EVAMPLIX 2022-10-28
"AXHAZA" 97652374	AXHAZA 2022-10-28
"IKAZEE" 97652311	IKAZEE 2022-10-28
"EVAMPLIX (BALSTILIMAB)" 90836060	EVAMPLIX (BALSTILIMAB) 2021-07-19
"Symbol/Image" 90835844	Symbol/Image 2021-07-19
"AGENTUS" 90608923	AGENTUS 2021-03-29
"STIMULON" 88705885	STIMULON 2019-11-25
"PSV" 88702838	PSV 2019-11-22
"AUTOSYNVAX" 88693944	AUTOSYNVAX 2019-11-15
"PHOSPHOSYNVAX" 88518917	PHOSPHOSYNVAX 2019-07-17
"A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN" 88282311	A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN 2019-01-30
"EVAMPLIX" 88260718	EVAMPLIX 2019-01-14
"IKAZEE" 88260647	IKAZEE 2019-01-14
"ZALIHANCE" 88260664	ZALIHANCE 2019-01-14
"AXHAZA" 88260701	AXHAZA 2019-01-14
"NOVOSIMILAR" 88048619	NOVOSIMILAR 2018-07-23
"ACTICUS" 87630678	ACTICUS 2017-10-02
"AGENTUS" 87502704	AGENTUS 2017-06-23
"AGENTUS" 87502674	AGENTUS 2017-06-23
"AIM" 87029377	AIM 2016-05-09
"ASV" 87013936	ASV 2016-04-26
"PSV" 87013956	PSV 2016-04-26
"BIONEXTGEN" 86924661	BIONEXTGEN 2016-03-01
"BIONEXGEN" 86924639	BIONEXGEN 2016-03-01
"AGENUS" 86863431	AGENUS 2015-12-31
"AGENUS" 86863464	AGENUS 2015-12-31
"AUTOPROVAX" 86860870	AUTOPROVAX 2015-12-29
"PHOSPHOSYNVAX" 86860907	PHOSPHOSYNVAX 2015-12-29
"ONCOPHAGE" 86856763	ONCOPHAGE 2015-12-22
"AUTOSYNVAX" 86826504	AUTOSYNVAX 2015-11-19
"THE PATIENT IS WAITING" 4212687 85403325	THE PATIENT IS WAITING 2011-08-22
"ARE WE GETTING ANY CLOSER?" 4212688 85403356	ARE WE GETTING ANY CLOSER? 2011-08-22
"THE PATIENT IS WAITING" 85195460	THE PATIENT IS WAITING 2010-12-10
"ARE WE GETTING ANY CLOSER?" 85195513	ARE WE GETTING ANY CLOSER? 2010-12-10
"SECANT" 4046024 77915883	SECANT 2010-01-20
"ONCOPHAGE" 3644943 78608250	ONCOPHAGE 2005-04-13
"ONCOPHAGE" 3644942 78608175	ONCOPHAGE 2005-04-13
"STIMULON" 2247694 75461889	STIMULON 1998-04-03
"ONCOPHAGE" 2280075 75435970	ONCOPHAGE 1998-02-18

Company Registrations

NCAGE Code	47HR6	AGENUS INC.
CAGE Code	47HR6	AGENUS INC.
DUNS	126130561	Agenus Inc.
SEC	0001098972	AGENUS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.